Skip to main content
Fig. 3 | Trials

Fig. 3

From: Effect of vitamin D supplementation versus placebo on recovery delay among COVID-19 Tunisian patients: a randomized-controlled clinical trial

Fig. 3

The recovery delays according to vitamin D supplementation (A) and hazard ratio (B). A The median duration of viral RNA conversion was 37 days (IQR: 29–45.50) in the intervention group and 28 days (IQR: 23–39) in the placebo group (p=0.010). B: HR was 1.58 (95% CI: 1.093–2.292, p=0.015). CI, confidence interval; HR, hazard ratio; RNA, ribonucleic acid; Vit D, vitamin D

Back to article page

Trials

ISSN: 1745-6215